Why is the "patent cliff" of 2026 creating a golden age for biosimilars and high-quality recombinant research reagents?
Sustainability has become a non-negotiable priority in 2026, leading to a surge in "green" protein production methods that move away from energy-intensive stainless steel tanks. A fascinating development in the recombinant proteins world is the rise of molecular pharming, where common crops like tobacco and lettuce are genetically engineered to act as living factories for therapeutic proteins....
0 Comments 0 Shares 349 Views 0 Reviews